weight management

Bariatric surgery costs vs. benefits: Plan coverage considerationsFrom a healthcare perspective, bariatric surgery is considered one of the most effective options for short-term and sustained weight loss. But does the investment pay off?
Make it personal: Three ways to connect with healthcare consumers: Remembering to engage in healthy behavior can often slip to the bottom of our list of priorities. In a world where we need to be reminded and motivated to be the healthiest version of ourselves, the right nudges at the right time can help us get there.
How providers, payers, employers should be fighting obesityBy addressing the root problem of obesity with structured programs, providers can help patients lose weight and very possibly avoid expensive chronic illnesses as a result. Employers and payers should incentivize healthy weight by paying for obesity care and treatment, potentially reaping substantial savings in the long term.
Insurer diabetes program engages consumers, lowers costs
Insurer diabetes program engages consumers, lowers costsAnthem Blue Cross recently launched a year-long diabetes prevention program to educate, treat and support its qualified California members who are at risk of developing type 2 diabetes.
New weight management pill available soonFDA recently approved the New Drug Application (NDA) for (lorcaserin HCl) CIV extended-release 20 mg tablets (Belviq XR, Eisai Inc. and Arena Pharmaceuticals), a once-a day dosing option for chronic weight management.
Pharmacist entrepreneur offers wellness screening to pharmaciesWellspring provides the questionnaires and the physicians, who evaluate the information. Pharmacies make nutritional suggestions when appropriate, and patients get more attention. The idea is, everybody benefits.
Managing the needs of female patientsOptometrists can play key roles in women’s health, especially in macular degeneration and obesity. Include a conversation about cosmetic use in discussions with female patients as well.
FDA grants approval to Novo Nordisk chronic weight management drugFDA has approved the new drug application (NDA) for liraglutide [rDNA origin] injection (Saxenda, Novo Nordisk) , the first once-daily glucagon-like peptide-1 (GLP-1) receptor agonist for chronic weight management.
FDA drug approvals December 2014
FDA committee recommends approval for liraglutide as anti-obesity drugLiraglutide 3 mg (Saxenda, Novo Nordisk) has been recommended by an FDA Advisory Committee to be approved for use in the treatment of obesity